BVF PARTNERS L P/IL Insider Trading $CBIO CATALYST BIOSCIENCES, INC.
Get free email notifications about insider trading for BVF PARTNERS L P/IL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of BVF PARTNERS L P/IL. BVF PARTNERS L P/IL is in KENT INTERNATIONAL HOLDINGS INC ($CRTQ) and 10% Owner in LIGAND PHARMACEUTICALS INC ($LGND) and 10% Owner in Capstone Therapeutics Corp. ($CAPS) and 10% Owner in REPLIGEN CORP ($RGEN) and 10% Owner in AVIGEN INC \DE ($AVGN) and 10% Owner in NEUROCRINE BIOSCIENCES INC ($NBIX) and 10% Owner in Astex Pharmaceuticals, Inc ($SUPG) and 10% Owner in ARQULE INC ($ARQL) and 10% Owner in NEUROBIOLOGICAL TECHNOLOGIES INC /CA/ ($NTII) and 10% Owner in RIGEL PHARMACEUTICALS INC ($RIGL) and 10% Owner in ARRAY BIOPHARMA INC ($ARRY) and 10% Owner in DYNAVAX TECHNOLOGIES CORP ($DVAX) and 10% Owner in EPIRUS Biopharmaceuticals, Inc. ($CRXX) and 10% Owner in CATALYST BIOSCIENCES, INC. ($CBIO) and 10% Owner in ICAGEN INC ($ICGN) and 10% Owner in ChemoCentryx, Inc. ($CCXI) and 10% Owner in Celera CORP ($CRA) and 10% Owner in ABBOTT BIOTHERAPEUTICS CORP ($FACT).
BVF PARTNERS L P/IL in CATALYST BIOSCIENCES, INC.
Trading Symbol: CBIOIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BVF PARTNERS L P/IL: 10% Owner
Holdings: 1,523,707 shares
Current Value: $898,987
Latest Transaction: Nov 19 2012
$CBIO Market Capitalization: $6.51M
$CBIO Previous Close: $0.59
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of BVF PARTNERS L P/IL in CATALYST BIOSCIENCES, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, FACT, ARQL, ARRY, SUPG, AVGN, CAPS, CBIO, CRA, CCXI, DVAX, CRXX, ICGN, CRTQ, LGND, NTII, NBIX, RGEN, RIGL
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 19 2012 | CBIO | CATALYST BIOSCIENC ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 5.11 | 26,800 | 136,902 | 1,523,707 | 1.5 M to 1.5 M (+1.79 %) |
Nov 19 2012 | CBIO | CATALYST BIOSCIENC ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 5.11 | 46,700 | 238,558 | 2,646,619 | 2.6 M to 2.6 M (+1.80 %) |
Nov 19 2012 | CBIO | CATALYST BIOSCIENC ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 4.00 | 444,649 | 1,778,596 | 1,496,907 | 1.1 M to 1.5 M (+42.26 %) |
Nov 19 2012 | CBIO | CATALYST BIOSCIENC ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 4.00 | 772,063 | 3,088,252 | 2,599,919 | 1.8 M to 2.6 M (+42.24 %) |
Nov 09 2012 | CBIO | CATALYST BIOSCIENC ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 4.01 | 17,400 | 69,718 | 1,052,258 | 1 M to 1.1 M (+1.68 %) |
Nov 09 2012 | CBIO | CATALYST BIOSCIENC ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 4.01 | 31,929 | 127,933 | 1,827,856 | 1.8 M to 1.8 M (+1.78 %) |
Nov 09 2012 | CBIO | CATALYST BIOSCIENC ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 4.08 | 8,800 | 35,915 | 1,034,858 | 1 M to 1 M (+0.86 %) |
Nov 09 2012 | CBIO | CATALYST BIOSCIENC ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 4.08 | 14,300 | 58,361 | 1,795,927 | 1.8 M to 1.8 M (+0.80 %) |
Nov 02 2012 | CBIO | CATALYST BIOSCIENC ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 4.05 | 21,500 | 87,150 | 1,026,058 | 1 M to 1 M (+2.14 %) |
Nov 02 2012 | CBIO | CATALYST BIOSCIENC ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 4.05 | 36,100 | 146,331 | 1,781,627 | 1.7 M to 1.8 M (+2.07 %) |
Nov 02 2012 | CBIO | CATALYST BIOSCIENC ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 4.05 | 23,400 | 94,688 | 1,004,558 | 981.2 K to 1 M (+2.38 %) |
Nov 02 2012 | CBIO | CATALYST BIOSCIENC ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 4.05 | 6,700 | 27,112 | 1,745,527 | 1.7 M to 1.7 M (+0.39 %) |
Nov 02 2012 | CBIO | CATALYST BIOSCIENC ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 4.06 | 5,300 | 21,495 | 981,158 | 975.9 K to 981.2 K (+0.54 %) |
Nov 02 2012 | CBIO | CATALYST BIOSCIENC ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 4.06 | 46,700 | 189,401 | 1,738,827 | 1.7 M to 1.7 M (+2.76 %) |
Oct 20 2009 | CBIO | CATALYST BIOSCIENC ... | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 23.60 | 374,000 | 8,824,567 | 2,061,925 | 2.4 M to 2.1 M (-15.35 %) |
Oct 20 2009 | CBIO | CATALYST BIOSCIENC ... | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 23.60 | 108,000 | 2,548,271 | 2,435,925 | 2.5 M to 2.4 M (-4.25 %) |
Oct 20 2009 | CBIO | CATALYST BIOSCIENC ... | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 23.60 | 156,400 | 3,690,274 | 2,543,925 | 2.7 M to 2.5 M (-5.79 %) |
Jul 16 2009 | CBIO | CATALYST BIOSCIENC ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.99 | 6,000 | 17,965 | 2,700,325 | 2.7 M to 2.7 M (+0.22 %) |
Jul 16 2009 | CBIO | CATALYST BIOSCIENC ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.99 | 2,000 | 5,988 | 2,694,325 | 2.7 M to 2.7 M (+0.07 %) |
Jul 16 2009 | CBIO | CATALYST BIOSCIENC ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.99 | 1,516 | 4,539 | 2,692,325 | 2.7 M to 2.7 M (+0.06 %) |
Jul 13 2009 | CBIO | CATALYST BIOSCIENC ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.89 | 1,000 | 2,891 | 2,690,809 | 2.7 M to 2.7 M (+0.04 %) |
Jul 13 2009 | CBIO | CATALYST BIOSCIENC ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.89 | 1,200 | 3,470 | 2,689,809 | 2.7 M to 2.7 M (+0.04 %) |
Jul 13 2009 | CBIO | CATALYST BIOSCIENC ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.79 | 1,000 | 2,789 | 2,688,609 | 2.7 M to 2.7 M (+0.04 %) |
Jul 13 2009 | CBIO | CATALYST BIOSCIENC ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.79 | 1,000 | 2,789 | 2,687,609 | 2.7 M to 2.7 M (+0.04 %) |
Jul 13 2009 | CBIO | CATALYST BIOSCIENC ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.10 | 12,000 | 37,198 | 2,686,609 | 2.7 M to 2.7 M (+0.45 %) |
Jul 13 2009 | CBIO | CATALYST BIOSCIENC ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.10 | 4,000 | 12,399 | 2,674,609 | 2.7 M to 2.7 M (+0.15 %) |
Jul 13 2009 | CBIO | CATALYST BIOSCIENC ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.10 | 5,500 | 17,049 | 2,670,609 | 2.7 M to 2.7 M (+0.21 %) |
Page: 1